BIOMAT Database Logo BIOMAT Database Logo

[Fundamental and clinical evaluation of IRMA for serum cardiac myosin light chain I]. 1990

M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
Department of Nuclear Medicine, Hyogo College of Medicine, Nishinomiya.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Clinical evaluation of immunoradiometric assay for serum cardiac myosin light chain I].
May 1991, Kaku igaku. The Japanese journal of nuclear medicine,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Fundamental evaluation of IRMA for serum insulin].
February 1992, Kaku igaku. The Japanese journal of nuclear medicine,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Fundamental and clinical evaluation of IRMA for serum SPan-1 antigen].
April 1990, Kaku igaku. The Japanese journal of nuclear medicine,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Fundamental and clinical evaluation of IRMA for serum pancreatic oncofetal antigen (POA)].
February 1988, Kaku igaku. The Japanese journal of nuclear medicine,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Clinical significance of serum cardiac myosin light chain I in patients with muscular dystrophy].
August 1990, Rinsho shinkeigaku = Clinical neurology,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Clinical significance of serum cardiac myosin light chain I in patients with Duchenne muscular dystrophy].
February 1992, No to shinkei = Brain and nerve,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
February 1989, Rinsho byori. The Japanese journal of clinical pathology,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Myosin, cardiac myosin light chain].
November 2004, Nihon rinsho. Japanese journal of clinical medicine,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I.
April 2020, The Journal of biological chemistry,
M Suehiro, and H Naruse, and Y Fukuda, and M Morita, and M Fukuchi, and T Iwasaki
[Fundamental and clinical evaluation of an immunoradiometric assay kit for serum TSH: SUCROSEP TSH IRMA].
December 1986, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!